A Study on Bilayer Tablets for the Anti-Allergic Drug
Journal of Drug Discovery and Therapeutics · 2023
DOI: 10.32553/jddt.v11i2.462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Discovery and Therapeutics, 2023. Verfasst von Mr. Vivek Subhash Tarate und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The bilayer tablet formulations used for each individual layer should be compressible (i.e., the capacity of a material to undergo a reduction in volume as a result of an applied pressure) and compactable (i.e., the capacity of a powder to be transformed into tablets with strength during densification) on their own, i.e., they should show satisfactory reduction in volume and form mechanically sound and coherent solid bodies. A bigger contact area exists between the layers as a result of the increased surface roughness, which improves interlayer adhesion. Bilayer tablet characterisation in early formulation development has certain advantages, including Bilayer tablet interfacial strength should be quantified, unusual or extreme properties of compacted layers should be identified, lot-to-lot consistency of the produced tablets should be ensured, rational formulation development strategy followed, material failure mechanisms during tablet manufacturing should be explained, and tablet-specific factors' effects should be understood.
Zitieren
APA
Tarate, M. V. S., & Pati, D. J. (2023). A Study on Bilayer Tablets for the Anti-Allergic Drug. Journal of Drug Discovery and Therapeutics. https://doi.org/10.32553/jddt.v11i2.462
Vancouver
Tarate MVS, Pati DJ. A Study on Bilayer Tablets for the Anti-Allergic Drug. Journal of Drug Discovery and Therapeutics. 2023. doi:10.32553/jddt.v11i2.462
BibTeX
@article{Tarate2023,
author = {Tarate, Mr. Vivek Subhash and Pati, Dr. Jagdishchandra},
title = {A Study on Bilayer Tablets for the Anti-Allergic Drug},
journal = {Journal of Drug Discovery and Therapeutics},
year = {2023},
doi = {10.32553/jddt.v11i2.462}
}
EUVIMED